Castle Bioscience CEO Interviewed on Behind the Bell

In this episode of Behind the Bell, Castle Biosciences Founder & CEO Derek J. Maetzold shares the impact of $CSTL being #NasdaqListed on the company’s mission in developing innovative genomic tests. 

 

 

Watch more of Behind the Bell on Nasdaq.com: https://www.nasdaq.com/news-and-insig…

Posted in AZBio News.